http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200918050-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
filingDate 2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0527401db3e9fb7f8a59cf0600ec549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0340b677c65eaa2618f98719c98598e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8804dfb56b6d6285b4771f001d18381e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6916b2dbf89651a341d341f468440ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2239e9443131f196a7a303dcda6c2db9
publicationDate 2009-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200918050-A
titleOfInvention Stable formulations of thiadiazole derivative
abstract The present invention provides formulation parameters and manufacturing conditions for stable pharmaceutical compositions comprising N- {4-(2, 2-dimethyl-propionyl)-(5R)-5-[(2-ethylamino-ethanesulfonylamino)-methyl]-5-phenyl-4, 5-dihydro-[1, 3, 4]thiadiazol-2-yl} -2, 2-dimethyl-propionamide that minimize undesirable chiral conversion to the less active S enantiomeric form.
priorityDate 2007-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420122593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID350287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413070491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID230280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25167017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456143606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421182352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449316130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10197612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43551807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421015232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3804841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415788685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419705795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426004119

Total number of triples: 50.